Information Provided By:
Fly News Breaks for January 30, 2019
HCA
Jan 30, 2019 | 09:01 EDT
SunTrust analyst David MacDonald raised his price target on HCA Healthcare to $175 and kept his Buy rating after the company's "impressive" quarter marked by "solid" organic volumes, robust acuity and price, and "superb" cash flows". The analyst also points to HCA Healthcare's "sizable capex pipeline" that targets areas including IT improvements, expanded service offerings, and capacity expansion. MacDonald expects the company to continue to widen its competitive moat through its "robust cash flow and massive balance sheet".
News For HCA From the Last 2 Days
HCA
HCA
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.